{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:22:51Z","timestamp":1790097771890,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10096-019-03546-7","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T09:08:19Z","timestamp":1554455299000},"page":"1387-1393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Rat models of colistin nephrotoxicity: previous experimental researches and future perspectives"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7903-1106","authenticated-orcid":false,"given":"Cihan","family":"Heybeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet As\u0131","family":"Oktan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahide","family":"\u00c7avdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"3546_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ijantimicag.2016.09.010","volume":"48","author":"TB Tran","year":"2016","unstructured":"Tran TB, Velkov T, Nation RL et al (2016) Pharmacokinetics\/pharmacodynamics of colistin and polymyxin B: are we there yet? Int J Antimicrob Agents 48:592","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"3546_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","volume":"71","author":"A Ordooei Javan","year":"2015","unstructured":"Ordooei Javan A, Shokouhi S, Sahraei Z (2015) A review on colistin nephrotoxicity. Eur J Clin Pharmacol 71(7):801\u2013810. \n                    https:\/\/doi.org\/10.1007\/s00228-015-1865-4","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3546_CR3","doi-asserted-by":"publisher","first-page":"e02319","DOI":"10.1128\/AAC.02319-16","volume":"61","author":"AP Zavascki","year":"2017","unstructured":"Zavascki AP, Nation RL (2017) Nephrotoxicity of polymyxins: is there any difference between colistimethate and polymyxin B? Antimicrob Agents Chemother 61(3):e02319\u2013e02316. Published 2017 Feb 23. \n                    https:\/\/doi.org\/10.1128\/AAC.02319-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"3546_CR4","first-page":"2311","volume":"68","author":"H He","year":"2013","unstructured":"He H, Li JC, Nation RL et al (2013) Pharmacokinetics of four different brands of colistimethate and formed colistin in rats. J Antimicrob Chemother 68(10):2311\u20132317","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"3546_CR5","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/cid\/ciu061","volume":"58","author":"TP Gauthier","year":"2014","unstructured":"Gauthier TP, Lantz E, Frederick C, Masmouei H, Ruiz-Serrano L, Smith L, Wolowich WR, Abbo LM (2014) Variability within investigations of intravenous colistin: the scope of the problem. Clin Infect Dis 58(9):1340\u20131342. \n                    https:\/\/doi.org\/10.1093\/cid\/ciu061","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3546_CR6","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1128\/AAC.00101-06","volume":"50","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Kasiakou SK (2006) Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world. Antimicrob Agents Chemother 50(6):2274\u20132275","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3546_CR7","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1128\/AAC.00756-06","volume":"50","author":"J Li","year":"2006","unstructured":"Li J, Nation RL, Turnidge JD (2006) Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization. Antimicrob Agents Chemother 50(12):4231 author reply 4231-2","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3546_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/cid\/cit680","volume":"58","author":"RL Nation","year":"2014","unstructured":"Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD (2014) Consistent global approach on reporting of colistin doses to promote safe and effective use. Clin Infect Dis 58(1):139\u2013141. \n                    https:\/\/doi.org\/10.1093\/cid\/cit680","journal-title":"Clin Infect Dis"},{"key":"3546_CR9","unstructured":"American Society of Health System Pharmacists. Warning! Dosing confusion with colistimethate for injection. Available at: \n                    http:\/\/www.ashp.org\/DocLibrary\/Policy\/PatientSafety\/NANAlert-Colistimethatesodium.aspx\n                    \n                  . Accessed 30 December 2018."},{"issue":"3","key":"3546_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/jac\/dku441","volume":"70","author":"B Yun","year":"2014","unstructured":"Yun B, Azad MA, Wang J et al (2014) Imaging the distribution of polymyxins in the kidney. J Antimicrob Chemother 70(3):827\u2013829","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"3546_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/0972-5229.56048","volume":"13","author":"S Gupta","year":"2009","unstructured":"Gupta S, Govil D, Kakar PN et al (2009) Colistin and polymyxin B: a re-emergence. Indian J Crit Care Med 13(2):49\u201353","journal-title":"Indian J Crit Care Med"},{"issue":"19","key":"3546_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1152\/physiolgenomics.00076.2013","volume":"45","author":"MT Eadon","year":"2013","unstructured":"Eadon MT, Hack BK, Alexander JJ, Xu C, Dolan ME, Cunningham PN (2013) Cell cycle arrest in a model of colistin nephrotoxicity. Physiol Genomics 45(19):877\u2013888","journal-title":"Physiol Genomics"},{"issue":"9","key":"3546_CR13","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1128\/AAC.02587-12","volume":"57","author":"MA Azad","year":"2013","unstructured":"Azad MA, Finnin BA, Poudyal A et al (2013) Polymyxin B induces apoptosis in kidney proximal tubular cells. Antimicrob Agents Chemother 57(9):4329\u20134335","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"3546_CR14","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1128\/AAC.00343-13","volume":"57","author":"G Ozkan","year":"2013","unstructured":"Ozkan G, Ulusoy S, Orem A et al (2013) How does colistin-induced nephropathy develop and can it be treated? Antimicrob Agents Chemother 57(8):3463\u20133469","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3546_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/0886022X.2018.1489286","volume":"40","author":"B Ceylan","year":"2018","unstructured":"Ceylan B, Ozansoy M, K\u0131l\u0131\u00e7 \u00dc et al (2018) N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions. Ren Fail 40(1):423\u2013434","journal-title":"Ren Fail"},{"issue":"7","key":"3546_CR16","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/AAC.00070-14","volume":"58","author":"C Dai","year":"2014","unstructured":"Dai C, Li J, Tang S, Li J, Xiao X (2014) Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways. Antimicrob Agents Chemother 58(7):4075\u20134085","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3546_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1128\/AAC.03925-14","volume":"59","author":"C Dai","year":"2014","unstructured":"Dai C, Tang S, Deng S et al (2014) Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2\/HO-1 pathway. Antimicrob Agents Chemother 59(1):579\u2013585","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"3546_CR18","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/jac\/dkx185","volume":"72","author":"C Dai","year":"2017","unstructured":"Dai C, Tang S, Wang Y, Velkov T, Xiao X (2017) Baicalein acts as a nephroprotectant that ameliorates colistin-induced nephrotoxicity by activating the antioxidant defence mechanism of the kidneys and down-regulating the inflammatory response. J Antimicrob Chemother 72(9):2562\u20132569","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"3546_CR19","doi-asserted-by":"publisher","first-page":"e0136075","DOI":"10.1371\/journal.pone.0136075","volume":"10","author":"SH Lee","year":"2015","unstructured":"Lee SH, Kim JS, Ravichandran K, Gil HW, Song HY, Hong SY (2015) P-glycoprotein induction ameliorates colistin induced nephrotoxicity in cultured human proximal tubular cells. PLoS One 10(8):e0136075. Published 2015 Aug 19. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0136075","journal-title":"PLoS One"},{"issue":"6","key":"3546_CR20","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1681\/ASN.2016060606","volume":"28","author":"Y Hori","year":"2017","unstructured":"Hori Y, Aoki N, Kuwahara S et al (2017) Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity. J Am Soc Nephrol 28(6):1783\u20131791","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"3546_CR21","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1128\/AAC.00254-13","volume":"57","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Yamaguchi H, Ogura J, Kobayashi M, Yamada T, Iseki K (2013) Megalin contributes to kidney accumulation and nephrotoxicity of colistin. Antimicrob Agents Chemother 57(12):6319\u20136324","journal-title":"Antimicrob Agents Chemother"},{"key":"3546_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.biopha.2018.10.093","volume":"109","author":"R Heidari","year":"2019","unstructured":"Heidari R, Behnamrad S, Khodami Z, Ommati MM, Azarpira N, Vazin A (2019) The nephroprotective properties of taurine in colistin-treated mice is mediated through the regulation of mitochondrial function and mitigation of oxidative stress. Biomed Pharmacother 109:103\u2013111. \n                    https:\/\/doi.org\/10.1016\/j.biopha.2018.10.093","journal-title":"Biomed Pharmacother"},{"key":"3546_CR23","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.biopha.2018.10.001","volume":"108","author":"B Hanedan","year":"2018","unstructured":"Hanedan B, Ozkaraca M, Kirbas A, Kandemir FM, Aktas MS, Kilic K, Comakli S, Kucukler S, Bilgili A (2018) Investigation of the effects of hesperidin and chrysin on renal injury induced by colistin in rats. Biomed Pharmacother 108:1607\u20131616. \n                    https:\/\/doi.org\/10.1016\/j.biopha.2018.10.001","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3546_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4103\/1319-2442.235168","volume":"29","author":"Z Ghlissi","year":"2018","unstructured":"Ghlissi Z, Hakim A, Mnif H, Zeghal K, Rebai T, Boudawara T, Sahnoun Z (2018) Combined use of vitamins E and C improve nephrotoxicity induced by colistin in rats. Saudi J Kidney Dis Transpl 29(3):545\u2013553. \n                    https:\/\/doi.org\/10.4103\/1319-2442.235168","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"4","key":"3546_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.bjan.2018.01.017","volume":"68","author":"G Talih","year":"2018","unstructured":"Talih G, Esmao\u011flu A, Bayram A, Yazici C, Deniz K, Talih T (2018) Does dexmedetomidine prevent colistin nephrotoxicity? Rev Bras Anestesiol 68(4):383\u2013387. \n                    https:\/\/doi.org\/10.1016\/j.bjan.2018.01.017","journal-title":"Rev Bras Anestesiol"},{"issue":"1","key":"3546_CR26","doi-asserted-by":"publisher","first-page":"e01254","DOI":"10.1128\/AAC.01254-17","volume":"62","author":"MAK Azad","year":"2017","unstructured":"Azad MAK, Sivanesan S, Wang J et al (2017) Methionine ameliorates polymyxin-induced nephrotoxicity by attenuating cellular oxidative stress. Antimicrob Agents Chemother 62(1):e01254\u2013e01217. \n                    https:\/\/doi.org\/10.1128\/AAC.01254-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"3546_CR27","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1080\/0886022X.2016.1229995","volume":"38","author":"BY Arslan","year":"2016","unstructured":"Arslan BY, Arslan F, Erkalp K, Alag\u00f6l A, Sevdi MS, Y\u0131ld\u0131z G, K\u00fc\u00e7\u00fck SH, Alt\u0131nay S (2016) Luteolin ameliorates colistin-induced nephrotoxicity in the rat models. Ren Fail 38(10):1735\u20131740. \n                    https:\/\/doi.org\/10.1080\/0886022X.2016.1229995","journal-title":"Ren Fail"},{"issue":"3","key":"3546_CR28","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.etap.2014.03.004","volume":"37","author":"Z Ghlissi","year":"2014","unstructured":"Ghlissi Z, Hakim A, Sila A, Mnif H, Zeghal K, Rebai T, Bougatef A, Sahnoun Z (2014) Evaluation of efficacy of natural astaxanthin and vitamin E in prevention of colistin-induced nephrotoxicity in the rat model. Environ Toxicol Pharmacol 37(3):960\u2013966. \n                    https:\/\/doi.org\/10.1016\/j.etap.2014.03.004","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"3546_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00134-010-2038-7","volume":"37","author":"E Ozyilmaz","year":"2011","unstructured":"Ozyilmaz E, Ebinc FA, Derici U, Gulbahar O, Goktas G, Elmas C, Oguzulgen IK, Sindel S (2011) Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? Intensive Care Med 37(1):141\u2013146. \n                    https:\/\/doi.org\/10.1007\/s00134-010-2038-7","journal-title":"Intensive Care Med"},{"key":"3546_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cbi.2018.08.012","volume":"294","author":"NE Edrees","year":"2018","unstructured":"Edrees NE, Galal AAA, Abdel Monaem AR, Beheiry RR, Metwally MMM (2018) Curcumin alleviates colistin-induced nephrotoxicity and neurotoxicity in rats via attenuation of oxidative stress, inflammation and apoptosis. Chem Biol Interact 294:56\u201364. \n                    https:\/\/doi.org\/10.1016\/j.cbi.2018.08.012","journal-title":"Chem Biol Interact"},{"issue":"12","key":"3546_CR31","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1128\/AAC.00985-17","volume":"61","author":"SS Sivanesan","year":"2017","unstructured":"Sivanesan SS, Azad MAK, Schneider EK et al (2017) Gelofusine ameliorates colistin-induced nephrotoxicity. Antimicrob Agents Chemother 61(12):e00985\u2013e00917. Published 2017 Nov 22. \n                    https:\/\/doi.org\/10.1128\/AAC.00985-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"3546_CR32","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1128\/AAC.00328-11","volume":"55","author":"JM Yousef","year":"2011","unstructured":"Yousef JM, Chen G, Hill PA, Nation RL, Li J (2011) Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob Agents Chemother 55(9):4044\u20134049","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3546_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jac\/dkr483","volume":"67","author":"JM Yousef","year":"2011","unstructured":"Yousef JM, Chen G, Hill PA, Nation RL, Li J (2011) Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. J Antimicrob Chemother 67(2):452\u2013459","journal-title":"J Antimicrob Chemother"},{"key":"3546_CR34","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.2147\/DDDT.S56071","volume":"9","author":"F Fluri","year":"2015","unstructured":"Fluri F, Schuhmann MK, Kleinschnitz C (2015) Animal models of ischemic stroke and their application in clinical research. Drug Des Devel Ther 9:3445\u20133454. Published 2015 Jul 2. \n                    https:\/\/doi.org\/10.2147\/DDDT.S56071","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"3546_CR35","first-page":"63","volume":"6","author":"H Hackbarth","year":"1983","unstructured":"Hackbarth H, B\u00fcttner D, Jarck D, Pothmann M, Messow C, G\u00e4rtner K (1983) Distribution of glomeruli in the renal cortex of Munich Wistar Fr\u00f6mter (MWF) rats. Ren Physiol 6(2):63\u201371","journal-title":"Ren Physiol"},{"key":"3546_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1159\/000088171","volume":"25","author":"Q Wei","year":"2005","unstructured":"Wei Q, Wang MH, Dong Z (2005) Differential gender differences in ischemic and nephrotoxic acute renal failure. Am J Nephrol 25:491\u2013499","journal-title":"Am J Nephrol"},{"issue":"5","key":"3546_CR37","first-page":"600","volume":"50","author":"PV Turner","year":"2011","unstructured":"Turner PV, Brabb T, Pekow C, Vasbinder MA (2011) Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50(5):600\u2013613","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"1","key":"3546_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40560-015-0072-9","volume":"3","author":"M Gurjar","year":"2015","unstructured":"Gurjar M (2015) Colistin for lung infection: an update. J Intensive Care 3(1):3. \n                    https:\/\/doi.org\/10.1186\/s40560-015-0072-9","journal-title":"J Intensive Care"},{"key":"3546_CR39","first-page":"505","volume":"16","author":"RE Lewis","year":"1966","unstructured":"Lewis RE, Kunz AL, Bell RE (1966) Error of intraperitoneal injections in rats. Lab Anim Care 16:505\u2013509","journal-title":"Lab Anim Care"},{"issue":"2","key":"3546_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/toxsci\/kft247","volume":"137","author":"ND Keirstead","year":"2014","unstructured":"Keirstead ND, Wagoner MP, Bentley P, Blais M, Brown C, Cheatham L, Ciaccio P, Dragan Y, Ferguson D, Fikes J, Galvin M, Gupta A, Hale M, Johnson N, Luo W, McGrath F, Pietras M, Price S, Sathe AG, Sasaki JC, Snow D, Walsky RL, Kern G (2014) Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers. Toxicol Sci 137(2):278\u2013291. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kft247","journal-title":"Toxicol Sci"},{"key":"3546_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/0023677011911345","volume":"35","author":"DB Morton","year":"2001","unstructured":"Morton DB, Jennings M, Buckwell A, Ewbank R, Godfrey C, Holgate B, Inglis I, James R, Page C, Sharman I, Verschoyle R, Westall L, Wilson AB, Joint Working Group on Refinement (2001) Refining procedures for the administration of substances. Report of the BVAAWF\/FRAME\/RSPCA\/UFAW Joint Working Group on Refinement. British Veterinary Association Animal Welfare Foundation\/Fund for the Replacement of Animals in Medical Experiments\/Royal Society for the Prevention of Cruelty to Animals\/Universities Federation for Animal Welfare. Lab Anim 35:1\u201341","journal-title":"Lab Anim"},{"issue":"1","key":"3546_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrneph.2017.142","volume":"14","author":"K Azushima","year":"2018","unstructured":"Azushima K, Gurley SB, Coffman TM (2018) Modelling diabetic nephropathy in mice. Nat Rev Nephrol 14(1):48\u201356. \n                    https:\/\/doi.org\/10.1038\/nrneph.2017.142","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"3546_CR43","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ijantimicag.2005.09.004","volume":"26","author":"ME Falagas","year":"2005","unstructured":"Falagas ME, Fragoulis KN, Kasiakou SK, Sermaidis GJ, Michalopoulos A (2005) Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents 26(6):504\u2013507","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"3546_CR44","doi-asserted-by":"publisher","first-page":"542","DOI":"10.2215\/CJN.06980717","volume":"13","author":"TA Miano","year":"2018","unstructured":"Miano TA, Lautenbach E, Wilson FP, Guo W, Borovskiy Y, Hennessy S (2018) Attributable risk and time course of colistin-associated acute kidney injury. Clin J Am Soc Nephrol 13(4):542\u2013550. \n                    https:\/\/doi.org\/10.2215\/CJN.06980717","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"3546_CR45","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1053\/j.ajkd.2016.03.421","volume":"68","author":"E Fiaccadori","year":"2016","unstructured":"Fiaccadori E, Antonucci E, Morabito S, d\u2019Avolio A, Maggiore U, Regolisti G (2016) Colistin use in patients with reduced kidney function. Am J Kidney Dis 68(2):296\u2013306. \n                    https:\/\/doi.org\/10.1053\/j.ajkd.2016.03.421","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3546_CR46","first-page":"BR74","volume":"14","author":"A Hakim","year":"2008","unstructured":"Hakim A, Kallel H, Sahnoun Z, Badraoui R, Jammoussi K, Bouaziz M, Zeghal KM, Rebaii T (2008) Lack of nephrotoxicity following 15-day therapy with high doses of colistin in rats. Med Sci Monit 14(4):BR74\u2013BR77","journal-title":"Med Sci Monit"},{"issue":"8","key":"3546_CR47","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3109\/0886022X.2013.815091","volume":"35","author":"Z Ghlissi","year":"2013","unstructured":"Ghlissi Z, Hakim A, Mnif H, Ayadi FM, Zeghal K, Rebai T, Sahnoun Z (2013) Evaluation of colistin nephrotoxicity administered at different doses in the rat model. Ren Fail 35(8):1130\u20131135. \n                    https:\/\/doi.org\/10.3109\/0886022X.2013.815091","journal-title":"Ren Fail"},{"key":"3546_CR48","doi-asserted-by":"publisher","first-page":"F139","DOI":"10.1152\/ajprenal.00168.2012","volume":"303","author":"RA Zager","year":"2012","unstructured":"Zager RA, Vijayan A, Johnson AC (2012) Proximal tubule haptoglobin gene activation is an integral component of the acute kidney injury \u201cstress response\u201d. Am J Physiol Renal Physiol 303:F139\u2013F148","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"3546_CR49","doi-asserted-by":"publisher","first-page":"F1487","DOI":"10.1152\/ajprenal.00352.2012","volume":"303","author":"Q Wei","year":"2012","unstructured":"Wei Q, Dong Z (2012) Mouse model of ischemic acute kidney injury: technical notes and tricks. Am J Physiol Renal Physiol 303(11):F1487\u2013F1494. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00352.2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"3546_CR50","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1681\/ASN.2015070832","volume":"26","author":"M Caestecker de","year":"2015","unstructured":"de Caestecker M, Humphreys BD, Liu KD et al (2015) Bridging translation by improving preclinical study design in AKI. J Am Soc Nephrol 26(12):2905\u20132916","journal-title":"J Am Soc Nephrol"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03546-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03546-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03546-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T10:31:22Z","timestamp":1567074682000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03546-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3546"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03546-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}